Poslední zkoušky

EudraCT Number: 2004-000348-25 Sponsor Protocol Number: D6160C00031 Start Date: 2004-09-22
Sponsor Name: ASTRAZENECA
Full Title: GALLANT 8 - A 24-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy when Added to the Th...
Medical condition: To prevent vascular disease associated with insulin resistence.
Disease: Version SOC Term Classification Code Term Level
9.1 10053247 Insulin-requiring type 2 diabetes mellitus LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-001033-41 Sponsor Protocol Number: H6D-MC-LVFZ Start Date: 2004-09-22
Sponsor Name: ELI LILLY
Full Title: A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evluate the Efficacy and Safety of Tadalafil (2.5 mg e 5 mg) administered once daily to men with diabetes mellitus and erect...
Medical condition: Therapy of erectile disfunction to subjects with diabetes mellitus and erectile disfunction with a 2.5 mg or 5 mg daily dosing.
Disease: Version SOC Term Classification Code Term Level
6.1 10061461 PT
Population Age: Adults, Elderly Gender: Male
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-001551-11 Sponsor Protocol Number: Iloprost Start Date: 2004-09-22
Sponsor Name: Lund University Hospital
Full Title: Behandling av förhöjt pulmonellt arteriellt tryck med inhalerad iloprost
Medical condition: Nyfödda barn som är i behov av respiratorvård pga RDS, mekoniumaspiration eller primär lunghypertension
Disease: Version SOC Term Classification Code Term Level
Population Age: Preterm newborn infants, Newborns, Under 18 Gender: Male, Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-000646-20 Sponsor Protocol Number: C04-001 Start Date: 2004-09-21
Sponsor Name: ALEXION PHARMACEUTICALS INCORPORATED
Full Title: A Hemoglobin Stabilization and Transfusion Reduction Efficacy and Safety Clinical Investigation, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal...
Medical condition: paroxysmal nocturnal hemoglobinuria
Disease: Version SOC Term Classification Code Term Level
7.0 10034042 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed) IE (Completed) GB (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-000805-23 Sponsor Protocol Number: LEV102341 Start Date: 2004-09-21
Sponsor Name: GLAXO SMITHKLINE
Full Title: A national, multicentric, randomised, controlled trial. Applications of a critical pathway using LEVOFLOXACIN for the management of patients with abnormal PSA
Medical condition: prostatitis
Disease: Version SOC Term Classification Code Term Level
6.1 10038359 SOC
Population Age: Adults Gender: Male
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-001883-39 Sponsor Protocol Number: P02561 Start Date: 2004-09-21
Sponsor Name: Schering Plough Reserach Institute
Full Title: Study to Evaluate the Effect of the Coadministration of SCH 497079 (a Histamine 3 [H3] Receptor Antagonist) Plus Desloratadine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis Who Ha...
Medical condition: Seasonal Allergic Rhinitis
Disease: Version SOC Term Classification Code Term Level
7.0 10039776 LLT
Population Age: Adults Gender: Male, Female
Trial protocol: AT (Completed)
Trial results: View results
EudraCT Number: 2004-000185-12 Sponsor Protocol Number: CELC200A2401 / 2939107 Start Date: 2004-09-21
Sponsor Name: Orion Corporation, ORION PHARMA
Full Title: A long term, double-blind, randomized, parallel-group, carbidopa/levodopa controlled, multi-center study to evaluate the effect of Stalevo® in patients with Parkinson’s disease requiring initiation...
Medical condition: Parkinson's disease
Disease: Version SOC Term Classification Code Term Level
7.0 10061536 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed) SE (Completed) AT (Completed) GB (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-002249-11 Sponsor Protocol Number: BLQ-01-003-04 Start Date: 2004-09-20
Sponsor Name: BAUSCH&LOMB - IOM S.P.A.
Full Title: Double blind, randomized, multicenter, placebo-controlled, parallel-group design clinical trial of the efficacy and tolerability of cloriclomene hydrochloride capsules 100 mg TID in diabetic patien...
Medical condition: Mild to moderate non-proliferative diabetic retinopathy
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: View results
EudraCT Number: 2004-001600-12 Sponsor Protocol Number: F/2004/2. Start Date: 2004-09-20
Sponsor Name: OMNINVEST Kft.
Full Title: Fluval AB Vaccine Serologic Clinical Trial
Medical condition: Immunization of healthy people against influenza virus infections.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed)
Trial results: View results
EudraCT Number: 2004-000838-36 Sponsor Protocol Number: PX104.1.7-201 Start Date: 2004-09-20
Sponsor Name: Pharmexa A/S
Full Title: A Phase II trial evaluating the immunological and clinical efficay and safety of HER-2 Protein Autovac(TM) monotherapy in patients with metastatic breast cancer
Medical condition: Female patients with histologically proven metastatic or locally advanced breast cancer who have HER-2 overexpression in the primary tumour and/or a metastatic lesion.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: HU (Completed)
Trial results: (No results available)

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit